AbbVie
ABBV
#31
Rank
S$443.57 B
Marketcap
$251.01
Share price
4.70%
Change (1 day)
10.72%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of September 2024 : S$195.76 Billion

According to AbbVie's latest financial reports the company's total assets are S$195.76 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2024)

Total assets by year

Year Total assets Change
2023-12-31S$177.91 B-4.39%
2022-12-31S$186.08 B-6.06%
2021-12-31S$198.09 B-0.55%
2020-12-31S$199.18 B65.79%
2019-12-31S$120.14 B48.17%
2018-12-31S$81.08 B-14.36%
2017-12-31S$94.67 B-1.03%
2016-12-31S$95.66 B27.48%
2015-12-31S$75.04 B106.42%
2014-12-31S$36.35 B-1.73%
2013-12-31S$36.99 B12.01%
2012-12-31S$33.02 B30.65%
2011-12-31S$25.28 B-7.14%
2010-12-31S$27.22 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
S$299.57 B 53.03%๐Ÿ‡บ๐Ÿ‡ธ USA
S$127.85 B-34.69%๐Ÿ‡บ๐Ÿ‡ธ USA
S$103.19 B-47.28%๐Ÿ‡บ๐Ÿ‡ธ USA
S$124.04 B-36.63%๐Ÿ‡บ๐Ÿ‡ธ USA
S$74.42 B-61.98%๐Ÿ‡บ๐Ÿ‡ธ USA
S$38.64 B-80.26%๐Ÿ‡บ๐Ÿ‡ธ USA
S$106.04 B-45.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$143.21 B-26.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$4.82 B-97.54%๐Ÿ‡บ๐Ÿ‡ธ USA